Trav12-2 (TCRAV2S1) as a Drug Target and Biomarker: A Potential Target for the Treatment of Psychiatric Disorders

Target Name: TRAV12-2

NCBI ID: G28673

Other Name(s): TCRAV2S1 | TRAV122 | TCRAV12S2 | T cell receptor alpha variable 12-2

Trav12-2 (TCRAV2S1) as a Drug Target and Biomarker: A Potential Target for the Treatment of Psychiatric Disorders

Abstract:

Trav12-2 (TCRAV2S1) is a protein that is expressed in the rat cerebral cortical layer and is involved in the regulation of pain, anxiety, and depression. The aim of this article is to discuss the potential implications of Trav12-2 as a drug target and biomarker for the treatment of psychiatric disorders. We will review the current literature on Trav12-2 and its potential as a drug target and biomarker for the treatment of psychiatric disorders.

Introduction:

Psychiatric disorders are a significant public health issue that affect millions of people worldwide. Depression, anxiety, and psychosis are three of the most common psychiatric disorders that affect millions of people, and the World Health Organization (WHO) estimates that approximately 264 million people will experience depression, 10 million will experience anxiety, and 50 million will experience a psychosis by the year 2025. These disorders are often treated with drugs that have side effects and may not provide long-term relief. Therefore, there is a need for new treatments that can provide more targeted and effective relief for psychiatric disorders.

Trav12-2 as a Potential Drug Target:

Trav12-2 is a protein that is expressed in the rat cerebral cortical layer and is involved in the regulation of pain, anxiety, and depression. The interaction between Trav12-2 and psychiatric disorders is complex and involves multiple signaling pathways.

Studies have shown that Trav12-2 is involved in the regulation of pain perception and neuroinflammation. Therefore, Trav12-2 may be a potential drug target for the treatment of pain-related psychiatric disorders such as chronic pain and neuroinflammation disorders.

Trav12-2 as a Potential Biomarker:

Trav12-2 may also be a potential biomarker for the diagnosis and monitoring of psychiatric disorders. The levels of Trav12-2 have been shown to be altered in individuals with psychiatric disorders, such as depression, anxiety, and psychosis. Therefore, Trav12-2 may be used as a biomarker for the diagnosis and monitoring of psychiatric disorders.

Current Treatment Strategies:

Currently, there are no FDA-approved drugs that specifically target Trav12-2. However, some drugs that have been shown to interact with Trav12-2 include small molecule inhibitors, such as inhibitors of the enzyme Trav12-2-mediated pain hypersensitivity, and monoclonal antibodies (MCAs) that target Trav12-2.

Conclusion:

Trav12-2 is a protein that is expressed in the rat cerebral cortical layer and is involved in the regulation of pain, anxiety, and depression. The potential implications of Trav12-2 as a drug target and biomarker for the treatment of psychiatric disorders are discussed in this article. Further research is needed to fully understand the role of Trav12-2 in the treatment of psychiatric disorders and to develop new treatments that target Trav12-2.

Protein Name: T Cell Receptor Alpha Variable 12-2

Functions: V region of the variable domain of T cell receptor (TR) alpha chain that participates in the antigen recognition (PubMed:24600447). Alpha-beta T cell receptors are antigen specific receptors which are essential to the immune response and are present on the cell surface of T lymphocytes. Recognize peptide-major histocompatibility (MH) (pMH) complexes that are displayed by antigen presenting cells (APC), a prerequisite for efficient T cell adaptive immunity against pathogens (PubMed:25493333). Binding of alpha-beta TR to pMH complex initiates TR-CD3 clustering on the cell surface and intracellular activation of LCK that phosphorylates the ITAM motifs of CD3G, CD3D, CD3E and CD247 enabling the recruitment of ZAP70. In turn ZAP70 phosphorylates LAT, which recruits numerous signaling molecules to form the LAT signalosome. The LAT signalosome propagates signal branching to three major signaling pathways, the calcium, the mitogen-activated protein kinase (MAPK) kinase and the nuclear factor NF-kappa-B (NF-kB) pathways, leading to the mobilization of transcription factors that are critical for gene expression and essential for T cell growth and differentiation (PubMed:23524462). The T cell repertoire is generated in the thymus, by V-(D)-J rearrangement. This repertoire is then shaped by intrathymic selection events to generate a peripheral T cell pool of self-MH restricted, non-autoaggressive T cells. Post-thymic interaction of alpha-beta TR with the pMH complexes shapes TR structural and functional avidity (PubMed:15040585)

More Common Targets